文献速递泌尿系结石

输尿管软镜治疗孤立肾结石的系统评价

Efficacy and Safety of Ureteroscopy for Stone Disease in a Solitary Kidney: Findings From a Systematic Review.
PubMed 文献 · Urology · 2018-04-24

总体并发症114例(16.4%),无死亡病例,Clavien III级并发症低于0.5%。该综述确认输尿管软镜对该特殊人群有效、安全且可靠。

要点

  • 孤立肾结石行输尿管软镜总体并发症率为16.4%(114/693)。
  • 无死亡病例报告,Clavien III级并发症低于0.5%。
  • 输尿管软镜对孤立肾结石患者是有效、安全且可靠的技术。

核心结论

  • 该系统评价确认输尿管软镜对孤立肾结石患者有效、安全且可靠。

主要发现

  • 总体报告114例(16.4%)并发症。
  • 所有研究中均无死亡病例报告。
  • Clavien III级并发症记录于低于0.5%的患者。

关键数值与推荐

  • 总体并发症114例(16.4%),对象为693例孤立肾结石患者。
  • Clavien III级并发症低于0.5%,无死亡病例。

临床怎么用

  • 对孤立肾结石患者,输尿管软镜可作为兼顾结石清除与安全性的治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Management of stone disease in solitary kidney remains a difficult treatment entity for the urologist. The challenge exists to deliver high clearance while maintaining strong safety profile. Twelve eligible studies were included, comprising a total of 693 patients with a male:female ratio of 2:1. Overall, 114 (16.4%) complications were reported. No fatalities were reported in any of the studies. Clavien III complications were recorded in less than 0.5% of the patients. This review confirms the effectiveness, safety, and reliability of this technique for this unique cohort of patients.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Pietropaolo A, Jones P, Whitehurst L, et al. Efficacy and Safety of Ureteroscopy for Stone Disease in a Solitary Kidney: Findings From a Systematic Review. Urology. 2018. PMID: 29702154. doi:10.1016/j.urology.2018.03.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。